TY - JOUR
T1 - Correction to
T2 - Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 10.1007/s00259-021-05489-8)
AU - Roy, Sudipta
AU - Whitehead, Timothy D.
AU - Li, Shunqiang
AU - Ademuyiwa, Foluso O.
AU - Wahl, Richard L.
AU - Dehdashti, Farrokh
AU - Shoghi, Kooresh I.
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021
Y1 - 2021
N2 - The article “Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer”, written by Sudipta Roy, Timothy D. Whitehead, Shunqiang Li, Foluso O. Ademuyiwa, Richard L. Wahl, Farrokh Dehdashti, and Kooresh I. Shoghi, was originally published electronically on the publisher’s internet portal on July 30, 2021 without open access. With the author(s)’ decision to opt for Open Choice, the copyright of the article changed on August 22, 2021 to
AB - The article “Co‑clinical FDG‑PET radiomic signature in predicting response to neoadjuvant chemotherapy in triple‑negative breast cancer”, written by Sudipta Roy, Timothy D. Whitehead, Shunqiang Li, Foluso O. Ademuyiwa, Richard L. Wahl, Farrokh Dehdashti, and Kooresh I. Shoghi, was originally published electronically on the publisher’s internet portal on July 30, 2021 without open access. With the author(s)’ decision to opt for Open Choice, the copyright of the article changed on August 22, 2021 to
UR - http://www.scopus.com/inward/record.url?scp=85115338327&partnerID=8YFLogxK
U2 - 10.1007/s00259-021-05542-6
DO - 10.1007/s00259-021-05542-6
M3 - Comment/debate
AN - SCOPUS:85115338327
JO - European Journal of Nuclear Medicine and Molecular Imaging
JF - European Journal of Nuclear Medicine and Molecular Imaging
SN - 1619-7070
ER -